Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.55 |
| ▸ | DRD2 | P14416 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | QDPR | P09417 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | DRD5 | P21918 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31733726 | 1.00 | SLC6A4 (0.55) | SLC6A4DRD2ALDH1A1KMT2AQDPR | |
| SCHEMBL5536929 | 0.77 | SLC6A4 (0.61) | SLC6A4DRD2ALDH1A1KMT2AQDPR | |
| SCHEMBL31733788 | 0.76 | SLC6A4 (0.47) | SLC6A4DRD2ALDH1A1KMT2AQDPR | |
| Hydrochloric Acid SCHEMBL31556090 | 0.74 | QDPR (0.62) | SLC6A4ALDH1A1KMT2AQDPRSIGMAR1 | |
| SCHEMBL28508682 | 0.74 | SLC6A4 (0.57) | SLC6A4DRD2ALDH1A1KMT2AQDPR | |
| SCHEMBL5546728 | 0.73 | QDPR (0.64) | SLC6A4ALDH1A1KMT2AQDPRSIGMAR1 | |
| SCHEMBL7704740 | 0.71 | SLC6A4 (1.00) | SLC6A4DRD2 | |
| SCHEMBL5542027 | 0.70 | QDPR (0.58) | SLC6A4KMT2AQDPR | |
| SCHEMBL24915928 | 0.69 | SLC6A4 (0.46) | SLC6A4DRD2QDPRHTR6 | |
| SCHEMBL7033282 | 0.68 | QDPR (0.56) | SLC6A4QDPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025237891-A1 | QUINOLINE-2-CARBOXAMIDE DERIVATIVES AS RAD51 INHIBITORS FOR THE TREATMENT OF CANCER | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2025-11-20 | — | — | WO | disclosed |